Condition

Kidney Neoplasms

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 12 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials12

Recruiting4

Common interventions16

Lead sponsors shown12

Clinical trials

12 shown

Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment RecommendationsNCT07739121 · 2026-05-01

RECRUITING

Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) ImagingNCT07225114 · 2025-11-04

RECRUITING

HTL0039732 in Participants With Advanced Solid TumoursNCT05944237 · 2023-08-02

RECRUITING

Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney CancerNCT00033137 · 2002-05-13

RECRUITING

A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial EnrollmentNCT07814872 · 2026-09-01

NOT_YET_RECRUITING

Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly PatientsNCT05068180 · 2021-10-05

UNKNOWN

Study of Nivolumab for Advanced Cancers in IndiaNCT03444766 · 2018-03-06

COMPLETED

CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceNCT02900248 · 2017-10-02

TERMINATED

A Study of Varlilumab and Atezolizumab in Patients With Advanced CancerNCT02543645 · 2015-10-01

TERMINATED

Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic TumorsNCT02077933 · 2014-05-14

COMPLETED

A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue BiopsyNCT01218854 · 2012-03-20

COMPLETED

Robotic vs Laparoscopic and Open Surgery for Abdominopelvic CancersNCT07821775 · 2012-01-01

COMPLETED

Common interventions

alpelisibDRUG1 Combination of Varlilumab and AtezolizumabDRUG1 contrast agent perflutren lipidDRUG1 everolimusDRUG1 exemestaneDRUG1 Frontier large language modelsOTHER1 HTL0039732 CapsulesDRUG1 HTL0039732 Capsules or HTL0039732 tablets and atezolizumab infusionDRUG1 low-dose neuroleptanalgesiaDRUG1 Multidisciplinary tumour boardsOTHER1 Needle angle measurementDEVICE1 NivolumabDRUG1 No Intervention: Observational CohortOTHER1 PlaceboDRUG1 Provider determinedOTHER1 Ultrasound ImagingDEVICE1

Leading sponsors

Asan Medical Center 1 Assistance Publique - Hôpitaux de Paris 1 Bristol-Myers Squibb 1 Cancer Research UK 1 Celldex Therapeutics 1 CureOne 1 Harvard Medical School (HMS and HSDM) 1 National Cancer Institute (NCI) 1 National Institutes of Health Clinical Center (CC) 1 Novartis Pharmaceuticals 1 RenJi Hospital 1 UNC Lineberger Comprehensive Cancer Center 1

Trial status mix

COMPLETED4

RECRUITING4

TERMINATED2

NOT_YET_RECRUITING1

UNKNOWN1

Phase mix

PHASE14

PHASE22

PHASE42

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.